Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elena Losina, Ph.D.

Co-Author

This page shows the publications co-authored by Elena Losina and Ingrid Bassett.
Connection Strength

8.961
  1. Test and Treat TB: a pilot trial of GeneXpert MTB/RIF screening on a mobile HIV testing unit in South Africa. BMC Infect Dis. 2019 Feb 04; 19(1):110.
    View in: PubMed
    Score: 0.800
  2. Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa. J Acquir Immune Defic Syndr. 2017 04 01; 74(4):432-438.
    View in: PubMed
    Score: 0.704
  3. Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South Africa. J Acquir Immune Defic Syndr. 2016 Oct 01; 73(2):154-60.
    View in: PubMed
    Score: 0.680
  4. Finding HIV in hard to reach populations: mobile HIV testing and geospatial mapping in Umlazi township, Durban, South Africa. AIDS Behav. 2015 Oct; 19(10):1888-95.
    View in: PubMed
    Score: 0.634
  5. A randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trial. BMC Infect Dis. 2013 Aug 26; 13:390.
    View in: PubMed
    Score: 0.549
  6. Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa. J Acquir Immune Defic Syndr. 2012 Jan 01; 59(1):25-30.
    View in: PubMed
    Score: 0.489
  7. Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should. AIDS. 2010 Jan; 24 Suppl 1:S37-44.
    View in: PubMed
    Score: 0.426
  8. Changing contextual factors from baseline to 9-months post-HIV diagnosis predict 5-year mortality in Durban, South Africa. AIDS Care. 2021 12; 33(12):1543-1550.
    View in: PubMed
    Score: 0.226
  9. Identifying and predicting longitudinal trajectories of care for people newly diagnosed with HIV in South Africa. PLoS One. 2020; 15(9):e0238975.
    View in: PubMed
    Score: 0.224
  10. Assessing rates and contextual predictors of 5-year mortality among HIV-infected and HIV-uninfected individuals following HIV testing in Durban, South Africa. BMC Infect Dis. 2019 Aug 28; 19(1):751.
    View in: PubMed
    Score: 0.208
  11. Using national laboratory data to assess cumulative frequency of linkage after transfer to community-based HIV clinics in South Africa. J Int AIDS Soc. 2019 06; 22(6):e25326.
    View in: PubMed
    Score: 0.204
  12. High Medication Possession Ratios Associated With Greater Risk of Virologic Failure Among Youth Compared With Adults in a Nigerian Cohort. J Acquir Immune Defic Syndr. 2018 07 01; 78(3):322-328.
    View in: PubMed
    Score: 0.192
  13. Clinic-Based Urinary Lipoarabinomannan as a Biomarker of Clinical Disease Severity and Mortality Among Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Infected Adults in South Africa. Open Forum Infect Dis. 2017; 4(3):ofx167.
    View in: PubMed
    Score: 0.181
  14. Adolescent Linkage to Care After a Large-scale Transfer From a Hospital-based HIV Clinic to the Public Sector in South Africa. Pediatr Infect Dis J. 2017 03; 36(3):311-313.
    View in: PubMed
    Score: 0.175
  15. Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis. BMC Pulm Med. 2016 11 14; 16(1):147.
    View in: PubMed
    Score: 0.171
  16. Understanding HIV-infected patients' experiences with PEPFAR-associated transitions at a Centre of Excellence in KwaZulu Natal, South Africa: a qualitative study. AIDS Care. 2015; 27(10):1298-303.
    View in: PubMed
    Score: 0.157
  17. Social support and mental health among adults prior to HIV counseling and testing in Durban, South Africa. AIDS Care. 2015; 27(10):1231-40.
    View in: PubMed
    Score: 0.157
  18. Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal. HIV Med. 2015 Nov; 16(10):640-4.
    View in: PubMed
    Score: 0.154
  19. Value of urine lipoarabinomannan grade and second test for optimizing clinic-based screening for HIV-associated pulmonary tuberculosis. J Acquir Immune Defic Syndr. 2015 Mar 01; 68(3):274-80.
    View in: PubMed
    Score: 0.152
  20. HIV testing rates, prevalence, and knowledge among outpatients in Durban, South Africa: Time trends over four years. Int J STD AIDS. 2015 Sep; 26(10):704-9.
    View in: PubMed
    Score: 0.148
  21. The Linkage Outcomes of a Large-scale, Rapid Transfer of HIV-infected Patients From Hospital-based to Community-based Clinics in South Africa. Open Forum Infect Dis. 2014 Sep; 1(2):ofu058.
    View in: PubMed
    Score: 0.147
  22. Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study. BMC Infect Dis. 2014 Feb 26; 14:110.
    View in: PubMed
    Score: 0.142
  23. Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness. PLoS One. 2014; 9(1):e85197.
    View in: PubMed
    Score: 0.141
  24. The acceptability and feasibility of routine pediatric HIV testing in an outpatient clinic in Durban, South Africa. Pediatr Infect Dis J. 2013 Dec; 32(12):1348-53.
    View in: PubMed
    Score: 0.140
  25. Linkage to care following community-based mobile HIV testing compared with clinic-based testing in Umlazi Township, Durban, South Africa. HIV Med. 2014 Jul; 15(6):367-72.
    View in: PubMed
    Score: 0.139
  26. Factors associated with self-reported repeat HIV testing after a negative result in Durban, South Africa. PLoS One. 2013; 8(4):e62362.
    View in: PubMed
    Score: 0.134
  27. Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa. PLoS One. 2013; 8(1):e55305.
    View in: PubMed
    Score: 0.132
  28. Depressive symptoms and their impact on health-seeking behaviors in newly-diagnosed HIV-infected patients in Durban, South Africa. AIDS Behav. 2012 Nov; 16(8):2226-35.
    View in: PubMed
    Score: 0.130
  29. Barriers to care among people living with HIV in South Africa: contrasts between patient and healthcare provider perspectives. AIDS Care. 2013; 25(7):843-53.
    View in: PubMed
    Score: 0.129
  30. Routine HIV testing in adolescents and young adults presenting to an outpatient clinic in Durban, South Africa. PLoS One. 2012; 7(9):e45507.
    View in: PubMed
    Score: 0.129
  31. Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa. PLoS One. 2012; 7(8):e43281.
    View in: PubMed
    Score: 0.128
  32. Screening for acute HIV infection in South Africa: finding acute and chronic disease. HIV Med. 2011 Jan; 12(1):46-53.
    View in: PubMed
    Score: 0.114
  33. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis. 2010 Oct 01; 51(7):823-9.
    View in: PubMed
    Score: 0.112
  34. The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One. 2010 Mar 04; 5(3):e9538.
    View in: PubMed
    Score: 0.108
  35. Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr. 2009 Jun 01; 51(2):135-9.
    View in: PubMed
    Score: 0.102
  36. Routine, voluntary HIV testing in Durban, South Africa: correlates of HIV infection. HIV Med. 2008 Nov; 9(10):863-7.
    View in: PubMed
    Score: 0.097
  37. Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department. J Acquir Immune Defic Syndr. 2007 Oct 01; 46(2):181-6.
    View in: PubMed
    Score: 0.091
  38. Impact of Unplanned Care Interruption on CD4 Response Early After ART Initiation in a Nigerian Cohort. J Int Assoc Provid AIDS Care. 2017 Jan/Feb; 16(1):98-104.
    View in: PubMed
    Score: 0.043
  39. Age Matters: Increased Risk of Inconsistent HIV Care and Viremia Among Adolescents and Young Adults on Antiretroviral Therapy in Nigeria. J Adolesc Health. 2016 09; 59(3):298-304.
    View in: PubMed
    Score: 0.042
  40. High rates of unplanned interruptions from HIV care early after antiretroviral therapy initiation in Nigeria. BMC Infect Dis. 2015 Sep 30; 15:397.
    View in: PubMed
    Score: 0.040
  41. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis. PLoS Med. 2014 Sep; 11(9):e1001725.
    View in: PubMed
    Score: 0.037
  42. The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa. J Acquir Immune Defic Syndr. 2011 Jan 01; 56(1):26-35.
    View in: PubMed
    Score: 0.029
  43. Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. Clin Infect Dis. 2009 Dec 15; 49(12):1915-27.
    View in: PubMed
    Score: 0.027
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.